A jaundice meter is a medical device used to screen newborn babies for the presence of jaundice. It works by using light to detect the levels of bilirubin, a yellow pigment, in the baby's skin. Elevated bilirubin levels can indicate jaundice. The meter painlessly detects bilirubin levels through the skin and provides swift, non-invasive screening. Jaundice affects over 60% of newborn babies and in severe cases if left untreated can cause brain damage or hearing loss.

Market Dynamics:
The jaundice meter market is primarily driven by the increasing prevalence of jaundice among newborn infants. According to the World Health Organization (WHO), approximately 60% of all newborns develop jaundice worldwide and approximately 10-15% develop severe jaundice requiring phototherapy or exchange transfusion. Early detection and management of neonatal jaundice is crucial to prevent disabilities and death. Jaundice meters enable quick, non-invasive screening of jaundice levels, facilitating timely treatment. Moreover,advancements in jaundice meter technologies such as smartphone-based devices and wearable meters are further expected to support market growth over the forecast period. However, availability of alternative diagnostic methods and cheaper alternatives in certain markets may restrain market growth to some extent.

SWOT Analysis

Strength: Jaundice meter provides quick and accurate readings of bilirubin levels in neonates. It helps in early detection of jaundice which can prevent long-term health issues in newborns. Portable jaundice meters are easy to use and do not require highly trained staff to operate. They provide instant results at the point-of-care without needing to send blood samples to central laboratories.

Weakness: Jaundice meters are more expensive than traditional bilirubin testing methods which increases the costs of newborn screening programs. Some jaundice meters may lack accuracy and give inconsistent readings compared to laboratory tests.

Opportunity: There is considerable scope for jaundice screening in emerging markets of Asia Pacific and Latin America due to increasing birth rates and improving access to healthcare. Governments are implementing national newborn screening programs to reduce infant mortality which will drive the demand for jaundice meters. Technological advancements can further enhance the accuracy, portability and ease-of-use of jaundice monitoring devices.

Threats: Stringent regulations pertaining to the approval and marketing of medical devices poses challenges for market players. Economic slowdowns may negatively impact the expansions of public health programs focused on newborn screening in affected countries.

Key Takeaways

Global Jaundice Meter Market Size is expected to witness high growth over the forecast period owing to rising neonatal jaundice screening initiatives worldwide. The global jaundice meter market is estimated to be valued at US$ 93.09 Mn in 2023 and is expected to exhibit a CAGR of 4.6% over the forecast period 2023 to 2030.

The Asia Pacific region currently dominates the market and is projected to grow at the fastest pace during 2023-2030. China, India, and other developing Asian countries with large birth rates are major contributors to the regional market growth. Governments are focusing on expanding universal newborn screening through initiatives like the India Newborn Action Plan aiming to reduce infant mortality.

Key players: Key players operating in the jaundice meter market are Aegis Medicals, Refine Medical Technology, Delta Medical International, Micro Lab, and Dräger. Aegis Medicals dominates the market with their flagship Bilicheck non-invasive jaundice meter addressing an important need for affordable screening in developing countries. Refine Medical Technology offers high-end jaundice monitoring devices targeting NICU settings in developed markets.

Get More Insights On This Topic: https://www.ukwebwire.com/global-jaundice-meter-market-trends/